Cargando…

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer

STAT3 and STAT5 proteins are oncogenic downstream mediators of the JAK–STAT pathway. Deregulated STAT3 and STAT5 signaling promotes cancer cell proliferation and survival in conjunction with other core cancer pathways. Nuclear phosphorylated STAT3 and STAT5 regulate cell-type-specific transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wingelhofer, Bettina, Neubauer, Heidi A., Valent, Peter, Han, Xiaonan, Constantinescu, Stefan N., Gunning, Patrick T., Müller, Mathias, Moriggl, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087715/ https://www.ncbi.nlm.nih.gov/pubmed/29728695 http://dx.doi.org/10.1038/s41375-018-0117-x

Ejemplares similares

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
por: de Araujo, Elvin D., et al.
Publicado: (2019)

Direct Targeting Options for STAT3 and STAT5 in Cancer
por: Orlova, Anna, et al.
Publicado: (2019)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
por: Orlova, Anna, et al.
Publicado: (2017)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

STAT5 is Expressed in CD34(+)/CD38(−) Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
por: Hadzijusufovic, Emir, et al.
Publicado: (2020)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
por: Erdogan, Fettah, et al.
Publicado: (2022)

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
por: Maurer, Barbara, et al.
Publicado: (2020)

Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
por: Berger, Angelika, et al.
Publicado: (2014)

STAT3 and STAT5 Activation in Solid Cancers
por: Igelmann, Sebastian, et al.
Publicado: (2019)

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
por: Kosack, Lindsay, et al.
Publicado: (2019)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

A centric view of JAK/STAT5 in intestinal homeostasis, infection, and inflammation
por: Surbek, Marta, et al.
Publicado: (2021)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
por: Chen, Jinghong, et al.
Publicado: (2023)

Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
por: Gordziel, C, et al.
Publicado: (2013)

Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival
por: Rauth, Manuel, et al.
Publicado: (2019)

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2016)

The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective
por: Staerk, Judith, et al.
Publicado: (2012)

Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function
por: Xu, Ren, et al.
Publicado: (2009)

Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
por: Nivarthi, Harini, et al.
Publicado: (2018)

Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3
por: Tripolt, Sabrina, et al.
Publicado: (2021)

Correlation of malignancy parameters in colorectal carcinoma with up- and downstream signalling partners of STAT3
por: Müller, A, et al.
Publicado: (2009)

Acetylation and sumoylation control STAT5 activation antagonistically
por: Krämer, Oliver H., et al.
Publicado: (2012)

STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
por: Swoboda, Alexander, et al.
Publicado: (2021)

P993: INCREASED STAT5B LEVELS IN MYELOPROLIFERATIVE NEOPLASMS LEAD TO ENHANCED MEGAKARYOCYTIC DIFFERENTIATION CORRELATING WITH THROMBOSIS
por: Ploderer, Marie, et al.
Publicado: (2023)

A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment
por: Kadye, Rose, et al.
Publicado: (2020)

Signaling by STATs
por: Ivashkiv, Lionel B, et al.
Publicado: (2004)

The regulation of inflammation by interferons and their STATs
por: Rauch, Isabella, et al.
Publicado: (2013)

Structural and functional consequences of the STAT5B(N642H) driver mutation
por: de Araujo, Elvin D., et al.
Publicado: (2019)

STAT5B(N642H) is a driver mutation for T cell neoplasia
por: Pham, Ha Thi Thanh, et al.
Publicado: (2017)

Redox Regulation of STAT1 and STAT3 Signaling
por: Butturini, Elena, et al.
Publicado: (2020)

Activated STAT5 Confers Resistance to Intestinal Injury by Increasing Intestinal Stem Cell Proliferation and Regeneration
por: Gilbert, Shila, et al.
Publicado: (2015)

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
por: Warsch, Wolfgang, et al.
Publicado: (2012)

PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
por: Garces de los Fayos Alonso, I., et al.
Publicado: (2022)

A Recurrent STAT5B(N642H) Driver Mutation in Feline Alimentary T Cell Lymphoma
por: Kieslinger, Matthias, et al.
Publicado: (2021)

STAT signaling in inflammation
por: Kaplan, Mark H.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gbolf2qfigndcemhjhihoj0ooa